Myeloma in the young

Garima Goel, Sharada Rai, Astha Gupta, Ramdas Naik, Poornima Baliga

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction: Multiple myeloma (MM) is a neoplastic plasma cellproliferation involving the bone marrow and extraosseous tissueswhich usually occurs in the elderly, (aged, 60 to 70 years), whilepatients younger than 30 or 40 years account for only 0.3 and2.2 %,of all myelomas, respectively.Materials and Methods: The present study analyzed 7 patientsyounger than 40 years among 87 patients of MM who presentedto our hospital from 2005 to 2008. Complete diagnostic workupwas carried out for all the patients.Results: The youngest of the 7 patients included in the study wasa 30 year old female. All the patients had marrow involvement byneoplastic plasma cells.Conclusion: The survival of patients younger than 40years withMM is longer than observed in other series of patients of all ageswith MM.

Original languageEnglish
Pages (from-to)559-560
Number of pages2
JournalJournal of Clinical and Diagnostic Research
Volume5
Issue number3
Publication statusPublished - 2011

Fingerprint

Plasmas
Multiple Myeloma
Bone
Bone Marrow
Plasma Cells
Survival

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Clinical Biochemistry

Cite this

Goel, Garima ; Rai, Sharada ; Gupta, Astha ; Naik, Ramdas ; Baliga, Poornima. / Myeloma in the young. In: Journal of Clinical and Diagnostic Research. 2011 ; Vol. 5, No. 3. pp. 559-560.
@article{8f88fe8b66f4405a816fadec168ae3ff,
title = "Myeloma in the young",
abstract = "Introduction: Multiple myeloma (MM) is a neoplastic plasma cellproliferation involving the bone marrow and extraosseous tissueswhich usually occurs in the elderly, (aged, 60 to 70 years), whilepatients younger than 30 or 40 years account for only 0.3 and2.2 {\%},of all myelomas, respectively.Materials and Methods: The present study analyzed 7 patientsyounger than 40 years among 87 patients of MM who presentedto our hospital from 2005 to 2008. Complete diagnostic workupwas carried out for all the patients.Results: The youngest of the 7 patients included in the study wasa 30 year old female. All the patients had marrow involvement byneoplastic plasma cells.Conclusion: The survival of patients younger than 40years withMM is longer than observed in other series of patients of all ageswith MM.",
author = "Garima Goel and Sharada Rai and Astha Gupta and Ramdas Naik and Poornima Baliga",
year = "2011",
language = "English",
volume = "5",
pages = "559--560",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "3",

}

Goel, G, Rai, S, Gupta, A, Naik, R & Baliga, P 2011, 'Myeloma in the young', Journal of Clinical and Diagnostic Research, vol. 5, no. 3, pp. 559-560.

Myeloma in the young. / Goel, Garima; Rai, Sharada; Gupta, Astha; Naik, Ramdas; Baliga, Poornima.

In: Journal of Clinical and Diagnostic Research, Vol. 5, No. 3, 2011, p. 559-560.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Myeloma in the young

AU - Goel, Garima

AU - Rai, Sharada

AU - Gupta, Astha

AU - Naik, Ramdas

AU - Baliga, Poornima

PY - 2011

Y1 - 2011

N2 - Introduction: Multiple myeloma (MM) is a neoplastic plasma cellproliferation involving the bone marrow and extraosseous tissueswhich usually occurs in the elderly, (aged, 60 to 70 years), whilepatients younger than 30 or 40 years account for only 0.3 and2.2 %,of all myelomas, respectively.Materials and Methods: The present study analyzed 7 patientsyounger than 40 years among 87 patients of MM who presentedto our hospital from 2005 to 2008. Complete diagnostic workupwas carried out for all the patients.Results: The youngest of the 7 patients included in the study wasa 30 year old female. All the patients had marrow involvement byneoplastic plasma cells.Conclusion: The survival of patients younger than 40years withMM is longer than observed in other series of patients of all ageswith MM.

AB - Introduction: Multiple myeloma (MM) is a neoplastic plasma cellproliferation involving the bone marrow and extraosseous tissueswhich usually occurs in the elderly, (aged, 60 to 70 years), whilepatients younger than 30 or 40 years account for only 0.3 and2.2 %,of all myelomas, respectively.Materials and Methods: The present study analyzed 7 patientsyounger than 40 years among 87 patients of MM who presentedto our hospital from 2005 to 2008. Complete diagnostic workupwas carried out for all the patients.Results: The youngest of the 7 patients included in the study wasa 30 year old female. All the patients had marrow involvement byneoplastic plasma cells.Conclusion: The survival of patients younger than 40years withMM is longer than observed in other series of patients of all ageswith MM.

UR - http://www.scopus.com/inward/record.url?scp=79959313003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959313003&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 559

EP - 560

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 3

ER -